Serum Institute of India (SII) | Page 7 | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 25, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 25, 2025

Serum Institute of India (SII)

AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. Photo :Reuters
Covid-19 in Bangladesh

Beximco could start private sales of AstraZeneca vaccine next month

Private sales of the vaccine by Beximco could begin in Bangladesh next month, and at a retail price of about Tk1,125 ($13.27) per dose

Oxford-AstraZeneca's Covid-19 vaccine. Photo: Reuters.
Covid-19 in Bangladesh

India's Serum to sell AstraZeneca vaccine to Bangladesh at $4/dose

AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. Photo :Reuters
Coronavirus chronicle

India signs purchase order with Serum for AstraZeneca vaccine

FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo
Coronavirus chronicle

India wants Serum Institute to lower price of AstraZeneca shot

Small bottles labelled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Covid-19 in Bangladesh

Bangladesh relies solely on Serum, COVAX

FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo
Coronavirus chronicle

Brazil sees no limit on buying vaccines from India, eyes mid-January delivery

Vaccine delivery: Delhi says no reason for Dhaka to be concerned
Covid-19 in Bangladesh

Vaccine delivery: Delhi says no reason for Dhaka to be concerned

Representational image. Picture: Collected
Coronavirus chronicle

Serum Institute, Bharat Biotech pledge smooth Covid-19 vaccine roll-out

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha/File Photo/File Photo
Coronavirus chronicle

India's Serum Institute says to meet local demand for AstraZeneca vaccine for next two months, before exporting

Representational image. Photo: Collected
Covid-19 in Bangladesh

Co-ordination meeting held at DNCC to ensure smooth Covid-19 vaccination activities in the city

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha/File Photo/File Photo
Coronavirus chronicle

Serum Institute CEO sees AstraZeneca's vaccine as "very good" candidate

Serum Institute says in active talks with Indian govt around potential Covid-19 vaccines
Coronavirus chronicle

Serum Institute says in active talks with Indian govt around potential Covid-19 vaccines

FILE PHOTO: Men ride on a motorbike past a supply truck of India's Serum Institute, the world's largest maker of vaccines, which is working on a vaccine against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

Serum Institute to focus on supplying Covid-19 vaccine to India first

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net